Regarding the tumors expressing wild-type p53, promising approaches to treat cancers could be to block major p53 inhibitors, Mdm2 and MdmX, or viral E6 oncogene in HPV-driven cervical cancers [51]. Here, MDM4 is linked to cervical cancer.